基于分子遗传学和细胞遗传学特征的急性髓系白血病全球时空分布特征及区域风险分层模型
该研究联合分析了1995至2023年间发表的急性髓系白血病(AML)患者分子遗传学和细胞遗传学异常研究,发现分子遗传学异常发生率逐年上升而细胞遗传学异常总体呈下降趋势,并通过聚类分析和预后风险模型揭示欧洲分子遗传学异常或两类异常并存患者风险相对较低,而亚洲细胞遗传学异常患者风险相对较低。
要点
- 分子遗传学异常发生率逐年上升,细胞遗传学异常呈总体下降趋势。
- 欧洲分子遗传学异常或两类遗传学异常并存的AML患者风险相对较低。
- 亚洲细胞遗传学异常的AML患者风险相对较低。
核心结论
- 基于预后分类和区域风险分层,研究为不同地区AML风险水平提供了有价值的见解,并强调了基因突变、染色体异常及其共现在理解疾病发病机制和指导治疗策略中的临床意义。
研究设计与样本
- 收集并联合分析了1995年至2023年间发表的关于AML患者分子遗传学和细胞遗传学异常的研究。
主要发现
- 分子遗传学异常的发生率逐年上升,而细胞遗传学异常总体呈下降趋势。
- 通过聚类分析和建立的预后风险模型发现,欧洲分子遗传学异常或两类遗传学异常并存的AML患者风险相对较低。
- 亚洲细胞遗传学异常的AML患者风险相对较低。
- 在分子遗传学异常中,剪接体共突变占主导地位,而细胞遗传学异常之间的协同相关性极小。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Genetic abnormalities in acute myeloid leukaemia (AML) patients are usually conducted in small or regional studies; there is currently a lack of research on whether genetic abnormalities in each continent have regional specificity. In this study, we collected and jointly analysed studies published between 1995 and 2023 that reported on molecular and cytogenetic abnormalities of AML patients. Our findings reveal that the incidence of molecular genetic abnormalities has been increasing annually, whereas cellular genetic abnormalities show an overall declining trend. We performed cluster analysis and developed a prognostic risk model to uncover that AML patients with molecular genetic abnormalities, or both types of genetic abnormalities, have a relatively lower risk in Europe. In contrast, AML patients in Asia with cytogenetic abnormalities exhibit a comparatively lower risk. We also found that spliceosome co-mutations were dominant among molecular genetic abnormalities, but the synergistic correlation between cytogenetic abnormalities is minimal. Our study offers valuable insights in AML risk levels across different regions, based on prognostic classification and regional risk stratification, and underscores the clinical significance of gene mutations, chromosomal abnormalities, and their co-occurrence, highlighting their role in understanding the disease's pathogenesis and informing treatment strategies.
引用
- Xiao J, Xia Y, Yin F, et al. Global spatiotemporal distribution characteristics and regional risk stratification model of acute myeloid leukaemia based on molecular genetics and cytogenetic features. Br J Haematol. 2025. PMID: 40325927. doi:10.1111/bjh.20138
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。